CCCC

C4 Therapeutics, Inc.

3.08

USD

-0.23

-6.95%

Sep 23, 15:59 UTC -4

Closed

After-Market

3.07

-0.01

-0.26%

C4 Therapeutics, Inc. Profile

About

C4 Therapeutics Inc. is a biopharmaceutical company. It is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. C4 Therapeutics Inc. is based in WATERTOWN, Mass.

Info & Links

CEO

Andrew J. Hirsch

Headquarters

490 Arsenal Way, Suite 120
Watertown, MA 02472, UNITED STATES

Auditor

KPMG LLP

Share holders

100

Employees

104

C4 Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization²

377.93M

Enterprise Value

299.32M

Enterprise Value/EBITDA(ttm)

-2.65

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

11.59

Price to Book(mrq)

1.48

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-289.44%

Profit Margin(ttm)

-309.19%

Return on Equity(ttm)

-45.45%

Return on Invested Capital(ttm)

-49.10%

Return on Assets(ttm)

-30.90%

Income Statement

Revenue(ttm)

35.04M

Revenue Per Share(ttm)

0.28

Gross Profit(ttm)

35.04M

EBITDA(ttm)³

-112.83M

Net Income Available to Common(ttm)

-101.42M

Diluted EPS(ttm)

-1.00

Share Statistics

Beta (5Y Monthly)

2.94

52-Week Change

18.01%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

123.03M

Dividend Yield

0.00%

Float⁴

116.14M

% Held by Insiders

5.60%

% Held by Institutions

78.81%

Balance Sheet

Total Cash(mrq)

253.66M

Total Cash Per Share(mrq)

2.06

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.45%

Quick Ratio(mrq)

5.45%

Book Value Per Share(mrq)

2.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.24

Free Cash Flow(ytd)

-31.62M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.